Creso Pharma Ltd
ASX:CPH

Watchlist Manager
Creso Pharma Ltd Logo
Creso Pharma Ltd
ASX:CPH
Watchlist
Price: 0.008 AUD
Market Cap: 17.7m AUD

Operating Margin
Creso Pharma Ltd

-224.7%
Current
-430%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-224.7%
=
Operating Profit
-19.7m
/
Revenue
8.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
Creso Pharma Ltd
ASX:CPH
17.7m AUD
-225%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
498.4B USD
27%
CH
Roche Holding AG
SIX:ROG
261.1B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
213.6B GBP
24%
CH
Novartis AG
SIX:NOVN
210.5B CHF
33%
US
Merck & Co Inc
NYSE:MRK
263.7B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
42%
IE
Endo International PLC
LSE:0Y5F
212.8B USD
11%
US
Pfizer Inc
NYSE:PFE
142B USD
29%
No Stocks Found

Creso Pharma Ltd
Glance View

Market Cap
17.7m AUD
Industry
Pharmaceuticals

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

CPH Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-224.7%
=
Operating Profit
-19.7m
/
Revenue
8.8m
What is the Operating Margin of Creso Pharma Ltd?

Based on Creso Pharma Ltd's most recent financial statements, the company has Operating Margin of -224.7%.

Back to Top